Register Cart 0

Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back Subscribe

Editorial (Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value)

Author(s): Vural Ozdemir, Jean Armengaud, Laurette Dube, Ramy Karam Aziz and Bartha M. Knoppers

Volume 8, Issue 4, 2010

Page: [240 - 244] Pages: 5

DOI: 10.2174/187569210793368230

Keywords: Biomarkers, biotechnology foresight, gene-centric human proteome project, nutriproteomics, personalized nutrition, population biobanks, prospective policy, proteogenomics, metabolome, Health technology assessment (HTA), Human Proteome Project (HPP), Human Genome Project (HGP), Human Proteome Organization (HUPO), mass spectrometry, Brain-to-Society (BtS), nanotechnology, biotechnology, Low and middle-income countries

Next »

Rights & Permissions Print Cite

Article Metrics

20

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Metabolomics as a Functional Tool in Screening Gastro Intestinal Diseases: Where are we in High Throughput Screening?
Combinatorial Chemistry & High Throughput Screening

Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets
Current Pharmaceutical Design

Synthesis of a Sulfonamide Pyruvate Kinase M2 Activator for Cancer Therapy
Current Organic Synthesis

Estrogen Receptors as Therapeutic Targets in Breast Cancer
Current Topics in Medicinal Chemistry

The Multiple Roles of Vitamin D in Human Health. A Mini-Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)

Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System
Current Drug Targets

Synthesis and Cytotoxicity of 4-(2-Adamantyl)phenylalkylamines
Letters in Organic Chemistry

Antipsychotics as Psychosis Drugs and Neuroprotective Promoters Evaluated by Chemical QSAR - in silico and in vivo Studies
Letters in Drug Design & Discovery

Functional Chemical Groups that May Likely Become a Source for the Synthesis of Novel Central Nervous System (CNS) Acting Drugs
Central Nervous System Agents in Medicinal Chemistry

Chemoresistance in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents

Malaria Chemotherapy: Recent Advances in Drug Development
Recent Patents on Anti-Infective Drug Discovery

α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents
Anti-Cancer Agents in Medicinal Chemistry

Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer
Current Medicinal Chemistry

Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued)

Reconstructing the Hsp90/Tau Machine
Current Enzyme Inhibition

Editorial [Hot Topic: Radiopharmaceuticals: Pre-Clinical Evaluation (Guest Editor: Maria Filomena Botelho)]
Current Radiopharmaceuticals

Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials
Current Angiogenesis (Discontinued)

Skin Regeneration: The Possibilities
Recent Patents on Regenerative Medicine

Novel Drugs Targeting the c-Ring of the F<sub>1</sub>F<sub>O</sub>-ATP Synthase
Mini-Reviews in Medicinal Chemistry

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Current Neuropharmacology

© 2024 Bentham Science Publishers | Privacy Policy